Cyclin-dependent kinase 3

Cyclin-dependent kinase 3
Cyclin-dependent kinase 3, also known as CDK3, is a protein-coding gene that plays a crucial role in cell cycle regulation. It is a member of the cyclin-dependent kinase family, which are serine/threonine kinases that control the progression of the cell cycle by interacting with cyclins. CDK3 specifically interacts with cyclin C to form an active kinase complex.
Function[edit]
CDK3 is involved in the regulation of cell cycle progression by phosphorylating key substrates that control the transition between different phases of the cell cycle. It is primarily active during the G1 phase of the cell cycle and plays a role in promoting cell cycle entry and progression.
Structure[edit]
The CDK3 protein consists of several domains, including a kinase domain that is responsible for its enzymatic activity. It also contains cyclin-binding motifs that allow it to interact with cyclin C and form a functional kinase complex.
Regulation[edit]
The activity of CDK3 is tightly regulated by various mechanisms, including the binding of cyclin C and the phosphorylation of specific residues within the protein. Additionally, CDK inhibitors can modulate the activity of CDK3 and prevent aberrant cell cycle progression.
Clinical significance[edit]
Aberrant regulation of CDK3 has been implicated in various human diseases, including cancer. Dysregulation of CDK3 activity can lead to uncontrolled cell proliferation and tumor formation. Therefore, targeting CDK3 has emerged as a potential therapeutic strategy for cancer treatment.
See also[edit]
| Cell cycle proteins | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
